Program

  13 June, 2024
Date/Time
Activities
07.30 - 09.00 Registration Room Mandarin A
09.00 - 09.30 Opening Ceremony
  • Dr.Rangsun PARNPAI, Suranaree University of Technology, Nakhon Ratchasima, Thailand
  • Dr.Suchinda MALAIVIJITNOND, National Primate Research Center, Chulalongkorn University, Bangkok, Thailand
  • Dr.Pierre SAVATIER, INSERM, Stem Cell and Brain Research Institute, Lyon, France
  • Mr.Xavier GROSMAITRE, French Embassy in Thailand
  • Dr.Sompong KLAYNONGSRUANG, Director of Program Management Unit for Human Resources & Institutional Development, Research and Innovation, Bangkok, Thailand
  • Dr.Neung TEAUMROONG, Vice Rector Research and Technology Development, Suranaree University of Technology, Nakhon Ratchasima, Thailand
09.30 - 10.15 Plenary Lecture  Chair: Dr. Pierre SAVATIER
Sustainable retinal cell therapy
Dr. Masayo TAKAHASHI, Vision Care Inc., Kobe, Japan
10.15 - 10.45 Coffee and Poster Presentation
Organoid/disease modelling session  Chair: Dr.Jeong Tae Do
10.45 - 11.20 Regulation of insulin secretion in hPSC-derived pancreatic islet-like organoids
Dr. Yong-Mahn HAN, Graduate School of Medical Science & Engineering, KAIST, Daejeon, Korea
11.20 - 11.55 Capturing the full potential of human pluripotent stem cell-derived islet organoids for diabetes research
Dr. Adrian Kee Keong TEO, Stem Cells and Diabetes Laboratory, IMCB, A*STAR, Singapore
11.55 - 13.00 Lunch
Organoid/disease modelling session  Chair: Dr. Adrian Kee Keong TEO
13.00 - 13.35 Improving hematopoietic differentiation from human induced pluripotent stem cells by the modulation of hippo signaling with a diarylheptanoid derivative
Dr. Alisa TUBSUWAN, Stem Cell Research Group, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand
13.35 - 14.10 In vitro modeling of neurovascular disease and drug verification: Application of vascular smooth muscle cells and blood vessel organoids differentiated from patient-derived pluripotent stem cells
Dr. Jeong Tae DO, Department of Stem Cell and Regenerative Biotechnology, Konkuk University, Seoul, Korea
14.10 - 14.45 Stem cell-fate engineering and expanded pluripotent state
Dr. Jonathan Yuin-Han LOH, Cell Fate Engineering and Therapeutics Laboratory, IMCB, A*STAR, Singapore
14.45 - 15.15 Coffee and Poster Presentation
Organoid/disease modelling session  Chair: Dr. Yong-Mahn HAN
15.15 - 15.50 Induced pluripotent stem cells and their derived neurons as cell models for studies of the motochondrial disease MERRF syndrome
Dr. Yau-Huei WEI, Center for mitochondrial Medicine and Free Radical Research, Changhua Christian Hospital, Changhua, Taiwan
15.50 - 16.25 Generation of off-the-shelf iPSC-derived immune cells for disease modeling and therapeutic applications
Dr. Methichit WATTANAPANITCH, Siriraj Center for Regenerative Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Short Communication session  Chair: Dr. Yau-Huei WEI
16.25 - 16.45 Development of functional human induced pluripotent stem cell-derived nociceptor model for in vitro pain research
Dr. Nontawat CHUINSIRI, Institute of Dentistry, Suranaree University of Technology, Nakhon Ratchasima, Thailand
16.45 - 17.05 iPSC-derived astrocytes technology unveils aberrant CHCHD2-associated mitochondriopathy in Kii ALS/PDC
Dr. Nicolas LEVENTOUX, Department of Physiology, Keio University, School of Medicine, Tokyo, Japan
17.05 - 17.25 Do PBMCs have ambiguous intrinsic plasticity?
Ms. Kalayar Aye SAW, Department of Radiation Technology, Faculty of Associated Medical Sciences, Chiang Mai, Thailand